Allergy & Immunology
Recombinant allergens, hypoallergenic derivatives are potential type I allergy therapy
Published in Vaccine Weekly, April 26th, 2006
"Currently, diagnosis of type I allergy is performed using crude allergen extracts, which allow the identification of the allergen-containing source responsible for type I allergic symptoms (e. g., allergic rhino-conjunctivitis, asthma) but not the disease-eliciting molecules. With the introduction of recombinant allergens produced by molecular biology techniques, a large panel of allergenic molecules has become available," scientists in Austria reported.
"The application of these recombinant allergens for in vitro tests has led to new forms of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-04-26)
More Articles from Vaccine Weekly
- Anthrax Vaccine
N-fragment of edema factor is candidate antigen for anthrax vaccine - Avian Influenza Vaccine
Adenovirus-based vaccine protects against lethal H5N1 avian influenza - Helicobacter Vaccine
CTA1-DD adjuvant enhances immunity against Helicobacter pylori infection - Rotavirus Vaccine
Rectally delivered vaccine protects mice against rotavirus infection - SARS Vaccine
Inactivated Vero-cell SARS vaccine is safe and effective in monkeys - Alzheimer Disease
Targeting A-beta oligomers improves learning and memory - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
